TSX •
Healthcare •
Biotechnology •
Quote as of 09/08/2026 15:56
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeTSX
Market Capitalization41.54 mln
Float327 mln
Earnings Date09/10/2026
Piotroski F-Score
3
/ 9
Below average
Relative Strength
99
/ 100
Top performer
Debt / Equity
-0.25
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Payout Ratio
0%
No payout
Business Description
Sernova Biotherapeutics is a Canadian medical company working to develop treatments that use living cells to restore natural body functions lost to disease. Its core technology, the Cell Pouch, is a small implantable device that creates a stable, blood-supplied environment where therapeutic cells can survive and function long-term, while remaining retrievable if needed. Based in Mississauga, the company was previously known as Sernova Corp before adopting its current name in early 2025.